CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 717 enrolled
Drug / intervention
Guidelines-based asthma and rhinitis/rhinosinusitis therapydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01383941
NCT01383941N/ACompleted

Asthma Phenotypes in the Inner City (ICAC-19)

National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Jun 28, 2011·Updated Mar 16, 2017

In Brief

An observational study evaluating Guidelines-based asthma and rhinitis/rhinosinusitis therapy for Asthma and Rhinitis. Completed, enrolled 717 participants across 9 sites.

Detailed Summary

This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17 years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Rhinitis
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 28, 2011
Enrollment StartAug 1, 2011
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 15.0 years ago

Interventions

Guidelines-based asthma and rhinitis/rhinosinusitis therapydrug

All participants receive standardized asthma and rhinitis treatment. Asthma and rhinitis medication regimens were based on 1.) the National Asthma Education and Prevention Program (NAEPP) Expert Panel Report -3 (EPR-3) and 2.) the Rhinitis and its Impact on Asthma (ARIA) 2008 guidelines-derived treatment algorithms. References: 1.) J Allergy Clin Immunol 2007; Volume 120, Issue 5, Supplement s93-140. 2.) Allergy 2008; Volume 63, Issue Supplement s86, pages 7-160.